Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's product portfolio includes Iomab-B and Actimab-A.
Company profile
Website
Employees
Incorporated
Location
Fiscal year end
Former names
Actinium Pharmaceuticals inc
SEC CIK
IRS number
742963609
Latest filings (excl ownership)
D
$15M in equity / options, sold $5.14M, 108 investors
31 Dec 12
D
$750K in debt / options, sold $364K, 11 investors
3 Nov 11
D
$6M in equity / options, sold $4.13M, 65 investors
17 Oct 11
REGDEX
Notice of sale of securities
17 Apr 08
REGDEX/A
Notice of sale of securities (amended)
4 Jan 08
REGDEX
Notice of sale of securities
9 Aug 07
REGDEX
Notice of sale of securities
20 Mar 06
REGDEX/A
Notice of sale of securities (amended)
20 Mar 06
REGDEX
Notice of sale of securities
24 May 05
Latest ownership filings